Dr. Sharlene Gill, BSc (Pharm), MD, MPH, MBA, FACP, FRCP(C)

CCTG Gastrointestinal Disease Site Chair

Dr. Sharlene Gill is a medical oncologist specializing in gastrointestinal (GI) malignancies at BC Cancer – Vancouver.  She received a BSc. in Pharmacy, and MD from the University of British Columbia in 1996 followed by residencies in Internal Medicine and Medical Oncology, subsequently completing a fellowship in Gl Oncology at the Mayo Clinic (Rochester, MN) and a Masters of Public Health from the Harvard School of Public Health (Boston, MA) before returning to Vancouver where she is presently Professor of Medicine at the University of British Columbia.  In 2017, she completed an MBA from the Kenan-Flagler School of Business at the University of North Carolina.  Her areas of clinical expertise are in colorectal, pancreatic and hepatobiliary cancers.  She is actively engaged in education and clinical research, with over 100 peer-reviewed publications and book chapters to her credit.

"Clinical trials are essential to advance cancer research, to introduce new therapies and ultimately to improve outcomes for our patients."

Research Interests

  • Colorectal Cancer
  • Hepatobiliary Malignancies
  • Pancreatic Cancer
  • Phase II/III Clinical Trials
  • Health Outcomes Research

Publications

  • Current publications list at PubMed

CCTG Gastrointestinal Disease Site Committee page